Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	73,878,612	67,544,126	54,092,240	58,433,854	59,746,995	54,652,290
Market Cap Growth	22.02%	24.87%	-7.43%	-2.20%	9.32%	90.76%
Enterprise Value	74,012,879	67,525,830	54,470,492	57,778,382	59,669,232	54,358,190
Last Close Price	1038000.00	949000.00	760000.00	821000.00	893509.47	817318.74
PE Ratio	57.74	62.35	63.07	73.22	151.80	226.80
Forward PE	54.17	62.18	60.08	82.37	112.20	-
PS Ratio	15.08	14.85	14.64	19.47	38.10	46.92
PB Ratio	6.55	6.19	5.50	6.50	11.97	11.88
P/TBV Ratio	8.64	8.52	8.23	10.14	12.05	11.95
P/FCF Ratio	363.72	189.90	80.60	-	1235.91	875.48
P/OCF Ratio	36.00	40.71	32.46	61.31	131.43	270.44
PEG Ratio	2.76	3.19	3.45	3.32	3.45	-
EV/Sales Ratio	15.11	14.85	14.74	19.25	38.05	46.67
EV/EBITDA Ratio	33.29	35.19	33.97	44.72	85.35	124.54
EV/EBIT Ratio	46.14	51.15	48.91	58.74	111.05	185.66
EV/FCF Ratio	364.38	189.85	81.16	-	1234.30	870.77
Debt / Equity Ratio	0.13	0.14	0.19	0.28	0.26	0.17
Debt / EBITDA Ratio	0.64	0.77	1.19	1.95	1.85	1.80
Debt / FCF Ratio	6.99	4.18	2.85	-	26.74	12.57
Asset Turnover	0.29	0.27	0.23	0.24	0.22	0.19
Inventory Turnover	0.84	0.83	0.76	0.91	1.02	1.37
Quick Ratio	0.36	0.35	0.50	0.76	1.24	1.45
Current Ratio	1.45	1.43	1.33	1.54	2.55	2.97
Return on Equity (ROE)	12.02%	10.45%	9.12%	11.42%	8.21%	5.38%
Return on Assets (ROA)	5.84%	4.94%	4.27%	5.01%	4.67%	2.97%
Return on Capital (ROIC)	8.12%	6.84%	5.99%	6.91%	5.76%	3.52%
Return on Capital Employed (ROCE)	11.50%	9.80%	9.40%	7.90%	7.80%	5.00%
Earnings Yield	1.73%	1.60%	1.59%	1.37%	0.66%	0.44%
FCF Yield	0.27%	0.53%	1.24%	-0.01%	0.08%	0.11%
Buyback Yield / Dilution	-	-	-1.95%	-5.51%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.